Children's Hospital LA pauses use of Sarepta gene therapy for all patients
The FDA on Friday asked Sarepta to voluntarily halt shipments of the gene therapy after a muscular dystrophy patient who received a different, experimental treatment died. The company said it did not plan to comply with the request and would continue making the treatment available to ambulatory patients.
The company in June suspended use of Elevidys for patients whose disease had progressed to the point where they need a wheelchair after two teenagers died from liver failure after treatment.
Elevidys has full FDA approval for children with Duchenne Muscular Dystrophy who are still able to walk, but was given conditional approval for non-ambulatory patients.
Children's Hospital LA said its pause, effective July 18, has been communicated to "affected patient families while it awaits any further determination by the FDA."
The hospital is one of more than 70 authorized to administer Elevidys. Five other major children's hospitals asked by Reuters to comment on whether they planned to continue use of the gene therapy did not immediately respond.
Shares of Sarepta, down about 90% year-to-date, fell 5% on Monday to close at $13.32 on Nasdaq.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News
an hour ago
- Sky News
Rows of decomposing bodies that haven't been buried because of fierce fighting in Syrian city
The smell hit us before we turned the corner into the backyard of Sweida City's main hospital. Neatly laid out in lines were rows of white body bags: some of the victims of the vicious bloodletting which the mainly-Druze city has suffered over the past week. There are more than 90 corpses in the yard, now badly decomposing in the heat. They are still picking up bodies from the hospital's front garden as we arrive. They say they have been unable to bury them because of the fierce fighting around the Syrian city. Most of the dead here are unidentified and will be buried in a mass grave near the hospital in the hope that a full investigation will be launched in less turbulent times. Inside the hospital, we're taken through darkened corridors powered by a generator. The electricity and internet in the city and the surrounding villages are not working. Traumatised patients Food and water are scarce and the doctors say medical supplies are dwindling. The hospital is in a shockingly dirty state, and many of the people in it are traumatised and frightened. Dr Obeida Abu Fakher, who is the head of resident doctors, told us that the lack of medical supplies and poor hygiene were now threatening the condition of those saved in emergency operations, some carried out along hospital corridors because the operating rooms were full. "I think you can smell the bad smell coming from the wound?" Dr Fakher says to us, as another medic delicately replaces the bandage on a young man's leg. "This is a very big problem because all the patients we treated in the operations rooms are now (getting infected) and risk dying right here." The wards are packed with the civilian victims caught up in Syria's complex tribal and political violence - the worst since the toppling of the country's dictator Bashar al Assad by fighters backed by Turkey and led by former Islamist Ahmed al Sharaa. Among the victims is 21-year-old Hajar, who was nine months pregnant with her first baby when she was shot through both legs. Medics managed to save her life but not her baby - a victim of this brutal outbreak of violence before even being born. A male nurse openly weeps in the corner of the ward where Hajar is laying immobile on a dirty hospital bed. Hajar's bandages hold together her shattered legs and there's blood still caked on her feet. "She needs specialist operations which we cannot do right now," a doctor explains. Hajar is just one of the many casualties among the dozens crammed in this hospital, as well as the tens of thousands of others affected by what's happened over the past 10 days of brutality in Sweida. The UN estimates nearly 130,000 people have fled their homes. The death toll is still being calculated but is thought to be more than a thousand so far. We have driven through multiple Druze checkpoints to get here. The Druze-dominated area is extremely edgy now and bunkered down behind sand chicanes and armed barricades. The cycle of tit-for-tat kidnappings and revenge attacks between Druze and Arab Bedoin tribes in the city quickly spiralled into an international crisis when witnesses said some government forces sent in as peacekeepers went on to join Bedoin tribes in the killing spree and robbing of the Druze minority. Israeli forces, who had warned against any of the Syrian army operating in the area, intervened with airstrikes, killing hundreds of troops as well as civilians. It was an act of aggression which the new Syrian president would later describe as pushing the country into a "dangerous phase" and threatening its stability. Days of anarchy The Israeli bombings forced the government troops to withdraw and, in their absence, Druze militia demanding autonomy from Damascus, embarked on a rash of revenge attacks and kidnappings. Days of anarchy followed with thousands of Arab fighters including Islamic extremists massing on the area, pillaging and looting mainly Druze homes and businesses and engaging in pitched battles with Druze militia as well as civilians defending their homes and families. Shocking but mostly unverified social media posts showing executions and beheadings from both Druze and Arab accounts have fuelled the fear and fighting. There are misinformation and disinformation propaganda campaigns - many by Islamists - which are inciting the violence and cementing divisions. The beleaguered new Syrian leader thanked America and the UAE for brokering a ceasefire - but it is shaky and in its infancy, and there's a massive trust deficit all round which it is tentatively plastering. This is so much more than a bloody sectarian crisis - and comes at a time when Syria is emerging from more than a decade of civil war and is economically broken. The crisis is complex, multi-layered and drawing in others. Anadolu Agency quoted the Turkish foreign minister Hakan Fidan as warning that any attempt to divide Syria will be viewed as a threat to Turkish national security and lead to direct Turkish intervention. These are words that will chill the many millions of Syrians desperate for peace.
The Independent
3 hours ago
- The Independent
New research explains why wrinkles develop with age
Scientists at Binghamton University have experimentally shown that skin wrinkles as it ages due to a process where it stretches laterally and then contracts, forming creases. Associate Professor Guy German explained that the skin's mechanical properties degrade with age, causing increased lateral stretching driven by inherent forces within the skin. The research involved using a low-force tensometer on skin samples from individuals aged 16 to 91, providing experimental evidence for previously theoretical models of skin aging. This new finding complements existing knowledge that genetics, disease, sun exposure, and repeated muscle movements also contribute to the formation of wrinkles. Published in the Journal of the Mechanical Behavior of Biomedical Materials, the study did not investigate methods to prevent these newly identified forces, though external factors like sun damage are acknowledged.
Reuters
6 hours ago
- Reuters
Roche pauses shipments of Elevidys gene therapy outside US
July 22 (Reuters) - Roche Holding AG (ROG.S), opens new tab said on Tuesday it has paused all shipments of muscular disorder gene therapy Elevidys outside the U.S., echoing a similar decision by U.S. partner Sarepta Therapeutics (SRPT.O), opens new tab on Tuesday. The Swiss drugmaker said the pause, effective Tuesday, applies to new orders of Elevidys in countries outside the U.S. that reference the Food and Drug Administration as the basis for their local approval. The pause is voluntary and temporary, and applies to all patients with Duchenne muscular dystrophy regardless of their ability to walk, Roche said in an emailed statement. Roche acquired the commercial rights to Sarepta's Elevidys outside the United States in 2019. Bloomberg News first reported the development.
